The map is not for sale.
Independent maps and decision rights for specialty practice systems. We help clinics decide, get ready, and move — no vendor pays for rank.
Names are coverage intent for Line 01 — not rankings. Scores ship only after the method is public and timed in live clinics. Medikarta has no exclusive tie to any system on this list.
Join the panel →Research outputs. Clinic work. One sequence.
Market map
Every system a specialty practice actually runs on — who it fits, who it doesn’t, and who never makes the shortlist. Publishes after timed clinic runs.
Switch-readiness scorecard
Data structure, integrations, staff capacity, change risk, ops load. Verdict: ready, not yet, or wrong destination. Sold as Ready.
Sequencing is policy, not a product: clinics first, research second, vendor AR last. Charter →
Bad software wins when switching is terrifying.
Your practice system is operationally critical, switching is expensive, and every free assessment is funded by someone with a quota. So clinics freeze — and freezing is a decision too.
We sell decision quality and market truth — to clinics first, and to vendors only after our method is public enough to audit. Multi-vendor coverage from day one. No house system.
“Which hurts more — living with this EHR, or switching?”
Your workflow facts will build the map. The map stays independent.
We’re recruiting aesthetics / plastics / medspa practices for timed workflow runs and problem interviews. Panel members get early method drafts and analyst office hours when research ships — free of charge. Vendors fund nothing on this list.
Validation is starting. There is no scored map for sale yet — that is intentional.